A novel antioxidant, octyl caffeate, suppression of LPS/IFN-γ-induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells

Biochemical Pharmacology

Volumn 65, Issue 8, 2003, Pages 1383-1392

  Hsiao, George ^a   Shen, Ming Yi ^a   Chang, Wen Chiung ^a   Cheng, Yu Wen ^a   Pan, Shiow Lin ^b   Kuo, Yueh Hsiung ^c   Chen, Tzeng Fu ^a   Sheu, Joen Rong ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Antioxidant; Endotoxic shock; iNOS; LPS IFN ; MAPK; Octyl caffeate

Indexed keywords

CAFFEIC ACID; GAMMA INTERFERON; I KAPPA B; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; STRESS ACTIVATED PROTEIN KINASE; XANTHINE OXIDASE;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA MEDIA; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PEROXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SMOOTH MUSCLE FIBER;

EID: 0037446224     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00070-4     Document Type: Article

References (37)

1. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-143.
2. Feihl F., Waeber B., Liaudet L. Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol. Ther. 91:2001;179-213.
3. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
4. Beasley D., Schwarts J.H., Brenner B.M. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87:1991;602-608.
5. Taylor B.S., Geller D.A. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock. 13:2000;413-424.
6. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:1994;13725-13728.
7. Wells P.G., Kim P.M., Laposa R.R., Nicol C.J., Pharman T., Winn L.M. Oxidative damage in chemical teratogenesis. Mut. Res. 396:1997;65-78.
8. Kikuzaki H., Hisamoto M., Hirose K., Akiyama K., Taniguchi H. Antioxidant properties of ferulic acid and its related compounds. J. Agric. Food Chem. 50:2002;2161-2168.
9. Song Y.S., Park E.H., Hur G.M., Ryu Y.S., Lee Y.S., Lee J.Y., Kim Y.M., Jin C. Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett. 175:2002;53-61.
10. Soliman K.F., Mazzio E.A. In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc. Soc. Exp. Biol. Med. 218:1998;390-397.
11. Hsiao G., Teng C.M., Sheu J.-R., Cheng Y.-W., Lam K.K., Lee Y.M., Wu T.S., Yen M.H. Cinnamophilin as a novel antiperoxidative cytoprotectant and free radical scavenger. Biochim. Biophys. Acta. 1525:2001;77-88.
12. Marion M.B. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 2:1976;248-254.
13. Hsiao G., Teng C.M., Wu C.L., Ko F.N. Marchantin H as a natural antioxidant and free radical scavenger. Arch. Biochem. Biophys. 334:1996;18-26.
14. 2+ mobilization by phorbol ester in rat cultured vascular smooth muscle cells. Cell. Signal. 11:1999;899-907.
15. 15N ] nitrite in biological fluids Anal. Biochem. 126:1982;131-138.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Meth. 65:1983;55-63.
17. Marczin N., Carolyn Y.G., Catravas J.D. Induction of nitric oxide synthase by protein synthesis inhibition in aortic smooth muscle cells. Br. J. Pharmacol. 123:1998;1000-1008.
18. Fleming I., Gray G.A., Schott C., Stoclet J.C. Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. Eur. J. Pharmacol. 200:1991;375-376.
19. Buchwalow I.B., Podzuwei T., Bocker W., Samoilova V.E., Thomas S., Wellner M., Baba H.A., Robenek H., Schnekenburger J., Lerch M.M. Vascular smooth muscle and nitric oxide synthase. FASEB J. 16:2002;500-508.
20. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 410:2001;1103-1107.
21. Lien E., Ingalls R.R. Toll-like receptors. Crit. Care Med. 30:2002;S1-11.
22. Sanu S., LaVerda D., Qureshi N., Golenbock D.T., Beasley D. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ. Res. 89:2001;244-250.
23. Jones B.W., Means T.K., Heldwein K.A., Kean M.A., Hill P.J., Belisle J.T., Fenton M.J. Different toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol. 69:2001;1036-1044.
24. Zhang H., Chen X., Teng X., Snead C., Catravas J.D. Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells. Biochem. Pharmacol. 55:1998;1873-1880.
25. Hecker M., Preib C., Schini-Kerth V.B., Busse R. Antioxidants differentially affect nuclear factor κB-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett. 380:1996;224-228.
26. Ryu Y.S., Lee J.H., Seok J.H., Hong J.H., Lee Y.S., Lim J.H., Kim Y.M., Hur G.M. Acetaminophen inhibits iNOS gene expression in RAW 264.7 macrophages: differential regulation of NF-κB by acetaminophen and salicylates. Biochem. Biophys. Res. Commun. 272:2000;758-764.
27. Doi M., Shichiri M., Katsuyama K., Marumo F., Hirata Y. Cytokine-activated p42/p44 MAPKinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappa B activation in vascular smooth muscle cells. Hypertens. Res. 23:2000;59-67.
28. Jiang B. Persistent activation of nuclear factor-kappa B by interleukin-1 beta and subsequent inducible NO synthase expression requires extracellular signal-regulated kinase. Arterioscler. Thromb. Vasc. Biol. 21:2001;1915-1920.
29. Wadsworth T.L., Koop D.R. Effects of Ginkgo biloba extract (EGb761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem. Biol. Interact. 137:2001;43-58.
30. 2-terminal kinase/stress-activated protein kinase in RAW 264.7 murine macrophage cells. Infect. Immunol. 69:2001;1315-1321.
31. Chan E.D., Riches D.W. IFN-. gamma+LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 (MAPK) in a mouse macrophage cell line Am. J. Physiol. Cell. Physiol. 280:2001;C441-C450.
32. Baydoun A.R., Wileman S.M., Wheeler-Jones C.P., Marber M.S., Mann G.E., Pearson J.D., Closs E.I. Transmembrane signaling mechanisms regulating expression of cationic amino acid transporters and inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem. J. 344:1999;265-272.
33. Vasselon T., Hanlon W.A., Wright S.D., Detmers P.A. Toll-like receptor-2 (TLR2) mediates activation of stress-activated MAP kinase p38. J. Leukoc. Biol. 71:2002;503-510.
34. English J.M., Cobb M.H. Pharmacological inhibition of MAPK pathways. Trends Pharmacol. Sci. 23:2002;40-45.
35. Glauser M.P., Zanetti G., Baumgartner J.D., Cohen J. Septic shock: pathogenesis. Lancet. 338:1991;732-738.
36. Brandes R.P., Koddenberg G., Gwinner W., Kim D.Y., Kruse H.J., Busse R., Mugge A. Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. Hypertension. 33:1999;1243-1249.
37. Cuzzocrea S., Riley D.P., Caputi A.P., Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53:2001;135-159.